STRS Ohio’s Inhibrx INBX Stock Holding History

STRS Ohio’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,900	Closed	-$26.6K	–	2251
2025 Q1	$26.6K	Hold	1,900	–	–	﹤0.01%	1831
2024 Q4	$29.3K	Hold	1,900	–	–	﹤0.01%	1784
2024 Q3	$29.8K	Hold	1,900	–	–	﹤0.01%	1866
2024 Q2	$26.9K	Buy	+1,900	New	+$29.7K	﹤0.01%	1868

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

STRS Ohio's INBX Position: Q2 2025 in Review

STRS Ohio sold out of Inhibrx (INBX) in Q2 2025, closing a stake of 1,900 shares — an estimated $26.6K sold.

STRS Ohio first reported a position in INBX in Q2 2024 and held it in 4 quarters. The position peaked at $29.8K in Q3 2024. 88 funds tracked by Wall St. Rank hold INBX as of Q2 2025.

STRS Ohio reported no remaining Inhibrx position as of Q2 2025 after selling out during the quarter.
STRS Ohio sold 1,900 Inhibrx shares in Q2 2025, an estimated $26.6K.
STRS Ohio first reported a position in Inhibrx in Q2 2024 and held it in 4 quarters.
STRS Ohio's Inhibrx position peaked at $29.8K in Q3 2024.
88 funds tracked by Wall St. Rank held Inhibrx as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.